Cephalexin Export Market Intelligence: India's 223 Suppliers Shipping to 104 Countries — TransData Nexus 2026

Q: Who are the top cephalexin exporters from India?

The top cephalexin exporters from India are: 1. ALKEM LABORATORIES LIMITED — $242.6M (69.4% market share); 2. LUPIN LIMITED — $35.7M (10.2% market share); 3. AUROBINDO PHARMA LTD — $11.8M (3.4% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $10.6M (3.0% market share); 5. CIPLA LIMITED — $9.9M (2.8% market share). Together they account for 88.9% of India's total cephalexin export value.

Q: What is the total export value of cephalexin from India?

The total export value of cephalexin from India is $349.5M USD, recorded across 5,117 shipment transactions from 223 active exporters to 104 destination countries. The average shipment value is $68.3K.

Q: Which countries import cephalexin from India?

India exports cephalexin to 104 countries worldwide. The top importing countries are: UNITED STATES (82.2% share, $287.1M), SRI LANKA (5.2% share, $18.1M), AUSTRALIA (2.4% share, $8.4M), ECUADOR (1.7% share, $5.8M), TANZANIA (1.4% share, $4.9M). These five markets account for 92.8% of total export value.

Q: What is the HS code for cephalexin exports from India?

The primary HS code for cephalexin exports from India is 30042012. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of cephalexin exports from India?

The average unit price for cephalexin exports from India is $6.22 USD per unit, with prices ranging from $0.01 to $2346.45 depending on formulation, packaging, and order volume. The total market is valued at $349.5M across 5,117 shipments.

Q: Which ports handle cephalexin exports from India?

The primary ports for cephalexin exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.1% of shipments), SAHAR AIR (14.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.5% of shipments), NHAVA SHEVA SEA (INNSA1) (7.8% of shipments), DELHI AIR (6.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of cephalexin?

India is one of the world's leading exporters of cephalexin due to its large base of 223 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports cephalexin to 104 countries, demonstrating 53% global market coverage.

Q: What certifications do Indian cephalexin exporters need?

Indian cephalexin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import cephalexin from India?

There are 516 registered buyers importing cephalexin from India, spread across 104 countries. The repeat buyer rate is 60.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top cephalexin supplier from India?

ALKEM LABORATORIES LIMITED is the leading cephalexin exporter from India with a market share of 69.4% and total export value of $242.6M across 618 shipments. The top 5 suppliers together control 88.9% of total export value.

Suresh Sormare

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

Cephalexin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Cephalexin to the World

Between 2022 and 2026, India exported $349.5M worth of cephalexin across 5,117 verified shipments to 104 countries — covering 53% of world markets in the Antibiotics segment. The largest destination is UNITED STATES (82.2%). ALKEM LABORATORIES LIMITED leads with a 69.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30042012

Cephalexin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Cephalexin export data snapshot — $349.5M · 223 exporters · 104 countriesTransData Nexus · Indian Customs Data

Top Cephalexin Exporters from India

223 active exporters · Ranked by export value

View all 223 →

Top Cephalexin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ALKEM LABORATORIES LIMITED	$242.6M	618	3	69.4%
2	LUPIN LIMITED

Top Countries Importing Cephalexin from India

104 destination markets · Ranked by import value

All 104 countries →

Top Countries Importing Cephalexin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$287.1M	82.2%
2	SRI LANKA	$18.1M	5.2%
3	AUSTRALIA	$8.4M	2.4%
4	ECUADOR	$5.8M	1.7%
5	TANZANIA	$4.9M	1.4%
6	CANADA	$3.4M	1.0%
7	CONGO DR	$3.3M	1.0%
8	ETHIOPIA	$3.3M	0.9%
9	PERU	$2.3M	0.7%
10	KENYA	$1.5M	0.4%

UNITED STATES is India's largest cephalexin export destination, absorbing 82.2% of total exports worth $287.1M. The top 5 importing countries — UNITED STATES, SRI LANKA, AUSTRALIA, ECUADOR, TANZANIA — together account for 92.8% of India's total cephalexin export value. The remaining 99 destination countries collectively receive the other 7.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Cephalexin to India?

5 origin countries · Total import value: $168.2K

India imports cephalexin from 5 countries with a combined import value of $168.2K. The largest supplier is UNITED STATES ($146.5K, 16 shipments), followed by CROATIA and BRAZIL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Cephalexin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$146.5K	16	87.1%
2	CROATIA	$17.9K	56	10.6%
3	BRAZIL	$3.7K	4	2.2%
4	CYPRUS	$158	1	0.1%
5	CANADA	$24	2	0.0%

UNITED STATES is the largest supplier of cephalexin to India, accounting for 87.1% of total import value. The top 5 origin countries — UNITED STATES, CROATIA, BRAZIL, CYPRUS, CANADA — together supply 100.0% of India's cephalexin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Cephalexin — Export Intelligence Video

Visual overview of India's cephalexin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's cephalexin pharmaceutical import and export market — $349.5M in total trade, 223 verified manufacturers, and 104 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Cephalexin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Cephalexin is approved through Abbreviated New Drug Applications (ANDAs), allowing generic manufacturers to market the drug upon demonstrating bioequivalence to the reference listed drug. The FDA's Orange Book lists multiple approved ANDAs for Cephalexin, indicating a competitive market with numerous generic options available. This competitive landscape is reflected in the substantial export volume from India, with 223 active exporters supplying Cephalexin to the U.S. market.

The FDA employs Import Alerts to prevent the entry of products that appear to violate U.S. regulations. These alerts enable the agency to detain shipments without physical examination if there is evidence of non-compliance. As of March 2026, there are no active Import Alerts specifically targeting Cephalexin from India, suggesting that Indian exporters are largely compliant with FDA standards. However, exporters must remain vigilant, as the FDA continuously monitors compliance and can issue Import Alerts if violations are identified.

2EU & UK Regulatory Framework

In the European Union, Cephalexin is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). Manufacturers must demonstrate compliance with EU Good Manufacturing Practice (GMP) standards to obtain and maintain these authorizations. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates the approval and monitoring of Cephalexin, ensuring adherence to GMP and other regulatory requirements. Indian exporters targeting these markets must ensure their manufacturing facilities are compliant with EU and UK GMP standards and that their products meet the specific regulatory requirements of each jurisdiction.

3WHO Essential Medicines & Global Standards

Cephalexin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also subject to international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is crucial for ensuring the quality and efficacy of Cephalexin in international markets.

4India Regulatory Classification

In India, Cephalexin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including Cephalexin, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Cephalexin's primary patents have expired, leading to a robust generic market with significant competition. This competitive environment is evident in the substantial number of Indian exporters—223 active exporters—supplying Cephalexin to various international markets.

6Recent Industry Developments

In October 2025, the FDA updated Import Alert 98-07 to reinforce that all unauthorized e-cigarettes may be detained without physical examination. While this alert does not directly pertain to Cephalexin, it highlights the FDA's ongoing efforts to regulate imported products rigorously. Exporters should remain attentive to such regulatory updates to ensure compliance.

In February 2024, the EMA granted a positive opinion for Lexylan, a veterinary medicinal product containing cefalexin sodium, indicating ongoing regulatory activities related to Cephalexin derivatives in the European market. This development may influence market dynamics and regulatory considerations for human-use Cephalexin products.

These developments underscore the importance of continuous monitoring of regulatory changes and market trends to maintain compliance and competitiveness in the global pharmaceutical industry.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Cephalexin

Retail & reference prices across 9 markets vs. India FOB export price of $6.22/unit

Global Price Benchmark for Cephalexin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	The FDA Orange Book lists approved manufacturers for Cephalexin 500mg tablets, but does not provide pricing information.
United Kingdom	Data not available	GBP	The NHS Drug Tariff provides reimbursement prices for medications, but specific pricing for Cephalexin 500mg tablets is not readily accessible.
Germany	Data not available	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceuticals in Germany; however, specific pricing data for Cephalexin 500mg tablets is not publicly available.

Supply Chain Risk Assessment — Cephalexin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Cephalexin, a widely used antibiotic, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency poses a significant risk, as any disruption in the supply of these KSMs can halt API production, leading to shortages of the finished drug. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting the vulnerability of the supply chain.

Recent events have underscored this risk. In October 2025, environmental regulations in China led to the temporary shutdown of several chemical plants producing essential KSMs, causing a ripple effect in global API production. Such incidents emphasize the need for diversification in sourcing raw materials to mitigate potential supply chain disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high concentration among Indian exporters of Cephalexin. The top five exporters account for 88.9% of total exports, with ALKEM LABORATORIES LIMITED alone holding a 69.4% share. This concentration presents a single-source risk; any operational or regulatory issues faced by these key suppliers could significantly impact the global supply of Cephalexin.

To address such vulnerabilities, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at boosting domestic manufacturing of critical APIs and reducing import dependence. As of March 2025, the scheme has led to import savings of ₹1,362 crore and the establishment of domestic manufacturing capacity for 25 identified KSMs, DIs, and APIs. While this initiative is a positive step, its focus on specific products means that Cephalexin's supply chain risks remain pertinent.

Access Complete Cephalexin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,117 transactions across 104 markets.

Request Demo View Pricing

Frequently Asked Questions — Cephalexin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top cephalexin exporters from India?

The leading cephalexin exporters from India are ALKEM LABORATORIES LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, and 12 others. ALKEM LABORATORIES LIMITED leads with 69.4% market share ($242.6M). The top 5 suppliers together control 88.9% of total export value.

What is the total export value of cephalexin from India?

The total export value of cephalexin from India is $349.5M, recorded across 5,117 shipments from 223 active exporters to 104 countries. The average shipment value is $68.3K.

Which countries import cephalexin from India?

India exports cephalexin to 104 countries. The top importing countries are UNITED STATES (82.2%), SRI LANKA (5.2%), AUSTRALIA (2.4%), ECUADOR (1.7%), TANZANIA (1.4%), which together account for 92.8% of total export value.

What is the HS code for cephalexin exports from India?

The primary HS code for cephalexin exports from India is 30042012. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cephalexin

Cephalexin

Top Cephalexin Exporters from India

Top Countries Importing Cephalexin from India

Who Supplies Cephalexin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Cephalexin — Export Intelligence Video

Regulatory Landscape — Cephalexin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Cephalexin

Supply Chain Risk Assessment — Cephalexin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Cephalexin Trade Intelligence

Frequently Asked Questions — Cephalexin Exports from India

Who are the top cephalexin exporters from India?

What is the total export value of cephalexin from India?

Which countries import cephalexin from India?

What is the HS code for cephalexin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of cephalexin exports from India?

Which ports handle cephalexin exports from India?

Why is India a leading exporter of cephalexin?

What certifications do Indian cephalexin exporters need?

How many buyers import cephalexin from India?

What is the market share of the top cephalexin exporter from India?

Analysis Methodology